References
Rossi V, Levati L, Biondi A. Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR. Meth Mol Med. 2006;125:115–127.
Uchida A, Matsuo K,Tanimoto M, et al. Increase in the incidence of acute promylocytic leukemia during gefitinib treatment for advanced non-small cell lung cancer. N Engl J Med. 2005; 352:843.
Beaumont M, Sanz M, Carli PM, et al. Therapy-related acute promyelocytic leukemia. J Clin Oncol. 2003;21:2123–2137.
Detourmignies L, Castaigne S, Stoppa AM, et al. Therapy-related acute promyelocytic leukemia: a report on 16 cases. J Clin Oncol. 2003;21:2123–2137.
Alessandro P, Livio P, Francesco LC, et al. Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience. Blood. 2002;100:1972–1976.
Griesinger F, Metz M, Trumper L, et al. Secondary leukemia after cure for locally advanced NSCLC: alkylating type secondary leukemia after induction therapy with docetaxel and carboplatin for NSCLC IIIB. Lung Cancer. 2004;44:261–265.
Travis LB, Holowaty EJ, Bergfeldt K, et al. Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med. 1999;340:351–357.
Mistry AR, Felix CA, Whitmarsh RJ, et al. DNA topoisomerase in therapy-related acute promyelocytic leukemia. N Engl J Med. 2005;352:1529–1538.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ennishi, D., Sezaki, N., Senoo, T. et al. A Case of Acute Promyelocytic Leukemia during Gefitinib Treatment. Int J Hematol 84, 284–285 (2006). https://doi.org/10.1532/IJH97.06149
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1532/IJH97.06149